News | August 23, 2023
Briefs: Concord Biotech, Cian Healthcare and Eris Lifesciences
Eris Lifesciences enters into term loan agreement with Citi Bank
Eris Lifesciences enters into term loan agreement with Citi Bank
Exothera will manufacture Meissa’s MV-012-968 vaccine candidate under CGMP regulations to supply Phase 2 clinical trials
Approximately 60 to 78% of individuals diagnosed with Asthma also have concurrent Allergic Rhinitis
He mentioned that Thyroid disorders are a common health problem in Jammu and Kashmir
Envelta is the company’s non-opioid pain product candidate for acute and chronic pain
Women of all ages will get round-the-clock access to comprehensive treatment
Nearly 5000 executives and more than 350 exhibitors turned out at the largest post-pandemic pharma packaging event
Asthma patients are more likely to have an asthma attack during winter
The companies will leverage their respective proprietary technology platforms
RYALTRIS is a fixed-dose combination therapy that provides relief for the symptoms of SAR, both nasal and ocular, in one easy-to-use nasal spray
Subscribe To Our Newsletter & Stay Updated
